Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 50

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 50
---
 then in effect is the greater of $3.12 and the Market Price (as defined in the Series D Certificate of Designations)
then in effect (the “Series D Adjustment Price”), the Conversion Price shall automatically lower to the Series D
Adjustment Price.

On August 13, 2025, the Company
and the Investors of Series D Preferred Stock entered into an Amendment and Limited Waiver Agreement (the “Waiver Agreement”),
whereby the Investors (i) amended the Registration Rights Agreement to extend certain deadlines therein and (ii) waive certain provisions
of the Series D COD. Pursuant to the Waiver Agreement, the Company and the Series D Preferred Holders acknowledged that it was inefficient
and impracticable to file the Registration Statement prior to the consummation of additional closings. Accordingly, the filing deadline
with respect to the initial Registration Statement was extended to August 15, 2025; The Registration Statement on Form S-3 was filed on
August 11, 2025. Additionally, the “Effectiveness Deadline” with respect to the initial Registration Statement required to
be filed, shall be the earlier of the (A) October 15, 2025 (or, if such Registration Statement is subject to a full review by the SEC,
November 30, 2025 and (B) fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the
SEC that such Registration Statement will not be reviewed or will not be subject to further review and (ii) with respect to any additional
Registration Statements that may be required to be filed by the Company pursuant to this Waiver Agreement, the earlier of the (A) ninetieth
(90th) calendar day following the date on which the Company was required to file such additional Registration Statement and (B) fifth
(5th) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration
Statement will not be reviewed or will not be subject to further review. The Registration Statement on Form S-3 was declared effective
on August 15, 2025. Furthermore, during the second quarter of 2025, the Company issued shares of Common Stock (the “Existing Series
C Conversion Shares”) upon conversion of shares of Series C Preferred Stock at conversion prices below the Conversion Price of the
Series D Preferred Stock (the “Existing Series C Conversions”), which each of the Company